Preventive effects of protopanaxadiol and protopanaxatriol ginsenosides on liver inflammation and apoptosis in hyperlipidemic apoE KO mice

Genes and Nutrition

Volumn 7, Issue 2, 2012, Pages 319-329

  Jang, Soojeong ^a,b   Lim, Yunsook ^c   Valacchi, Giuseppe ^c,d   Sorn, Sungbin ^e   Park, Hyon ^c   Park, Na Young ^c   Lee, Myoungsook ^a,f  

^a Sungshin Women's University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c Kyung Hee University   (South Korea)

^d UNIVERSITY OF SIENA   (Italy)

^e Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^f Research Institute of Obesity Science   (South Korea)

Author keywords

Apo E KO mice; Apoptosis; Bcl 2; Caspase; Cleaved PARP; Ginsenosides; Hyperlipidemia; LPO; MAPK; NFjB

Indexed keywords

APOLIPOPROTEIN E; CASPASE 8; CASPASE 9; CHOLESTEROL; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RG 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; JANUS KINASE; LIPID PEROXIDASE; MALONALDEHYDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN C JUN; PROTOPANAXADIOL; PROTOPANAXATRIOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HEPATITIS; HYPERLIPIDEMIA; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALIA; MUS; PANAX GINSENG;

EID: 84860777809     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-011-0245-7     Document Type: Article

References (48)

1. Ajizian SJ, English BK, Meals EA (1999) Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179:939-944 (Pubitemid 29159340)
2. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD (1991) ERKs: a family of protein-serine/ threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675
3. Bray GA, Popkin BM (1998) Dietary fat intake does affect obesity. Am J Clin Nutr 68:1157-1173 (Pubitemid 28550944)
4. Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392-401
5. Cho JY, Yoo ES, Cha BC, Park HJ, Rhee MH, Han YN (2006a) The inhibitory effect of triterpenoid glycosides originating from Sanguisorba officinalis on tissue factor activity and the production of TNF-alpha. Planta Med 72:1279-1284
6. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK (2006b) Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocininduced diabetic rats. Eur J Pharmacol 550:173-179 (Pubitemid 44572271)
7. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99-S112
8. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) Tumor necrosis factor-a suppresses insulin-induced tyrosine posphorylation of insulin receptor and its substrate. J Biol Chem 268:26055-26058
9. Ferre N, Martinez-Clemente M, Lopez-Parra M, Gonzalez-Periz A, Horrillo R, Planaguma A, Camps J, Joven J, Tres A, Guardiola F, Bataller R, Arroyo V, Claria J (2009) Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. Am J Physiol Gastrointest Liver Physiol 296:G553-G562
10. Formiguera X, Canton A (2004) Obesity: epidemiology and clinical aspects. Best Pract Clin Gastroenterol 18:1125-1146 (Pubitemid 39517697)
11. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707-714 (Pubitemid 8110784)
12. Guo Y, Zhang C, Du X, Nair U, Yoo TJ (2005) Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice. Hear Res 208:54-67 (Pubitemid 41427129)
13. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860-867 (Pubitemid 46024993)
14. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesitylinked insulin resistance. Science (NY) 259:87-91 (Pubitemid 23036092)
15. Jang SJ, Kim SS, Lee M (2008) Hypolipidemic and antioxidant effects to ginseng extract (PD:PT = 1) in Apo E Null Mice. Korean J Nutr 41(7):594-601
16. Jou J, Choi SS, Diehl AM (2008) Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 28:370-379
17. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169-1196 (Pubitemid 38802622)
18. Kim H-J, Bo M-H, Lee J-W, Im H-G, Lee I-S (2007) Antioxidant effects of ginseng powder on liver on benzo(a)pyrene-treated mice. Korean J Food Sci Technol 39(2):217-221
19. Kim JH, Kang SA, Han SM, Shim I (2009) Comparison of the antiobesity effects of the protopanaxadiol- and protopanaxatrioltype saponins of red ginseng. Phytother Res 23:78-85
20. Kwok HH, Ng WY, Yang MS, Mak NK, Wong RN, Yue PY (2010) The ginsenoside protopanaxatriol protects endothelial cells from hydrogen peroxide-induced cell injury and cell death by modulating intracellular redox status. Free Radic Biol Med 48:437-445
21. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160 (Pubitemid 24153440)
22. Lee M, Bae MA (2007) Docosahexaenoic acid induces apoptosis in CYP2E1-containing HepG2 cells by activating the c-Jun N-terminal protein kinase related mitochondrial damage. J Nutr Biochem 18:348-354 (Pubitemid 46590716)
23. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746
24. Lee CK, Han YN, Kim NY, Choi JW (2003) The therapeutic effects of Korean ginsneg on carbone tetrachrolide- and galactosamineinduced hepatotoxicity. J Ginseng Res 27:1-10
25. Lee SH, Seo GS, Ko G, Kim JB, Sohn DH (2005) Anti-inflammatory activity of 20(S)-protopanaxadiol: enhanced heme oxygenase 1 expression in RAW 264.7 cells. Planta Med 71:1167-1170 (Pubitemid 43107066)
26. Lee M, Sorn S, Baek S, Jang S, Kim S (2009) Antioxidant and apoptotic effects of Korean white ginseng extracted with the same ratio of Protopanaxadiol and Protopanaxatriol saponins in human hapatoma hepG2 cells. Ann N Y Acad Sci 1171:217-227
27. Lin WM, Zhang YM, Moldzio R, Rausch WD (2007) Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. J Neural Transm Suppl 72:105-112
28. Liu CX, Xiao PG (1992) Recent advances on ginseng research in China. J Ethnopharmacol 36:27-38
29. Liu G, Wang B, Zhang J, Jiang H, Liu F (2009) Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression. J Ethnopharmacol 126:350-354
30. Liu R, Zhang J, Liu W, Kimura Y, Zheng Y (2010a) Anti-obesity effects of protopanaxdiol types of Ginsenosides isolated from the leaves of American ginseng (Panax quinquefolius L.) in mice fed with a high-fat diet. Fitoterapia 81:1079-1087
31. Liu Y, Zhang HG, Jia YY, Li XH (2010b) Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits. Biol Pharm Bull 33:1324-1330
32. Lohmann C, Schäfer N, Lukowicz TV, Stein S, Borén J, Rü tti S, Wahli W, Donath MY, Lüscher TF, Christian Matter M (2009) Atherosclerotic and visceral adipose tissue, liver, and pancreatic islet. Atherosclerosis 7(2):360-367
33. Mari M, Caballero F, Colell A, Morales A, Caballeria J, Fernandez A, Enrich C, Fernandez-Checa JC, Garcia-Ruiz C (2006) Mitochondrial free cholesterol loading sensitizes to TNF- and Fasmediated steatohepatitis. Cell Metab 4:185-198 (Pubitemid 44307975)
34. Mayr M, Mayr U, Chung YL, Yin X, Griffiths JR, Xu Q (2004) Vascular proteomics: linking proteomic and metabolomic changes. Proteomics 4:3751-3761 (Pubitemid 39657452)
35. Oh SH, Lee BH (2004) A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage. Toxicol Appl Pharmacol 194:221-229
36. OhGS, PaeHO,ChoiBM, SeoEA, KimDH, ShinMK,Kim JD,KimJB, Chung HT (2004) 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase- 2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett 205:23-29 (Pubitemid 38230135)
37. Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, Yoo YB, Ko YC, Jun WT, Park HJ (2002) Possible role of ginsenoside Rb1 on regulation of rat liver triglycerides. Biol Pharm Bull 25:457-460
38. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183 (Pubitemid 32458157)
39. Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, Bruno S, Mangano C, Polito I, Amato F, Cotichini R, Stroffolini T, Mele A, ACE Collaborating Group (2005) Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 41:1151-1159 (Pubitemid 40593924)
40. Shibata S, Tanaka O, Ando T, Sado M, Tsushima S, Ohsawa T (1966) Chemical studies on oriental plant drugs. XIV. Protopanaxadiol, a genuine sapogenin of ginseng saponins. Chem Pharm Bull (TOKYO) 14:595-600
41. Valen G, Yan ZQ, Hansson GK (2001) Nuclear factor kappa-B and the heart. J Am Coll Cardiol 38:307-314 (Pubitemid 32721754)
42. Vassault A, Sebille L, Bailly M (1981) Evaluation according to the NCCLS protocol of the Kodak-Ektachem procedure applied to the estimation of glucose and urea in plasma (author's transl). Ann Biol Clin 39:17-28 (Pubitemid 11183727)
43. Vergnes L, Phan J, Strauss M, Tafuri S, Reue K (2003) Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278:42774-42784 (Pubitemid 37345887)
44. Wan JB, Lee SM, Wang JD, Wang N, He CW, Wang YT, Kang JX (2009) Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion. J Agric Food Chem 57:6692-6697
45. Widmann C, Gibson S, Jarpe MB, Johnson GL (1999) Mitogenactivated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:43-80
46. Wouters K, van Gorp PJ, Beighs V, Gijbels MF, Lutjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B, van Bilsen M, Shiri-Sverdlov R, Hofker MH (2008) Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48:474-486
47. Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, Wu JA, Aung HH, Rue AP, Bell GI, Yuan CS (2005) Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 1740:319-325 (Pubitemid 40804743)
48. Zhang Z, Li X, Lv W, Yang Y, Gao H, Yang J, Shen Y, Ning G (2008) Ginsenoside Re reduces insulin resistance through inhibition of c-Jun NH2-terminal kinase and nuclear factorkappaB. Mol Endocrinol (Baltimore, Md) 22:186-195